Lupin informs about press release

03 Jul 2019 Evaluate

Lupin has informed about Press Release as regards receipt of US FDA approval by the Company for Phenylephrine and Ketorolac Intraocular Solution, 1%/0.3%, which is the generic version of Omidria Intraocular Solution, 1%/0.3%, of Omeros Corporation. This is considered as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2138.65 -12.40 (-0.58%)
01-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.20
Dr. Reddys Lab 1182.75
Cipla 1325.85
Zydus Lifesciences 878.80
Lupin 2138.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×